期刊文献+

具有高同位素丰度氘标记的4'-羟基双氯芬酸的合成 被引量:1

Synthesis of deuterium labelled 4′-hydroxy diclofenac with improved isotopic enrichment
原文传递
导出
摘要 目的设计合成非甾体类抗炎镇痛药双氯芬酸的活性代谢物4'-羟基双氯芬酸的药物标准品——含4个氘原子标记的4'-羟基双氯芬酸。方法以氘标记苯乙酸为起始原料,经取代、酰胺化反应得4个氘原子标记的中间体4;再以苯酚为原料,经2步反应得中间体7;中间体4与中间体7经Ullmann缩合、脱甲基、水解反应得目标产物——氘标记的4'-羟基双氯芬酸。结果与结论目标化合物的总收率为15.1%,其结构经1H-NMR和MS谱确证,最终产物的同位素丰度超过98%;化学纯度经HPLC测定达98.5%。 Diclofenac is a non-steroidal anti-inflammatory drug(NSAID). 4'-Hydroxy diclofenac is the principal human metabolite of diclofenac. The synthesis of four-deuterium-labelled 4'-hydroxy diclofenac in seven steps was described. Five-deuterium-labelled phenyl acetic acid was chosen as the starting material. After substitution and amidation, 2- ( 2-iodo [ 2^ H4 ] phenyl) -N, N-dimethylacetamide ( 4 ) was obtained. 2,6-Dichlo- ro-4-methoxyaniline(7) ,another key intermediate,was synthesized from phenol treated with sodium nitrite in sulphuric acid, followed by continuous passage of dry hydrogen chloride gas into methanol. After Ullmann coupling between 4 and 7, followed by demethylation and hydrolysis, the target compound 4'-hydroxy di- clofenac was obtained. The total yield was 15. 1% with 98.5% chemical purity and over 98% isotopic enrichment. The structure of the target compound was confirmed by 1^H-NMR and MS. It is used as excellent internal standard for the pharmaceutical studies of diclofenac.
出处 《中国药物化学杂志》 CAS CSCD 2012年第1期21-25,共5页 Chinese Journal of Medicinal Chemistry
关键词 氘标记 4'-羟基双氯芬酸 高同位素丰度 合成 deuterium labelled 4'-hydroxy diclofenac improved isotopic enrichment synthesis
  • 相关文献

参考文献12

  • 1ALFRED R S. The history of diclofenac [J ]. Am J Med,1986,80(4,Suppl. 2) :29 -33.
  • 2BANDARAGE U K, CHEN L, FANG X, et al. Ni- trosothiol esters of diclofenac: synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs [ J ]. J Med Chem, 2000,43 ( 21 ) : 4005 - 4016.
  • 3TAMURA Y, UENISHI J, CHIO H D, et al. Synthesis of diclofenac [ J ]. Chem Pharm Bull, 1984,32 ( 5 ) : 1995 - 1997.
  • 4RIESS W,STIERLIN H,DEGEN P,et al. Pharmacokinetics and metabolism of the anti-inflammatory agent voltaren [J ]. Scand J Rheumatol ( Suppl. ), 1978,22(22) :17 -29.
  • 5胡爱萍,胡国新.双氯芬酸的制剂及药代动力学特点[J].温州医学院学报,2005,35(1):80-82. 被引量:8
  • 6IAN W. Synthesis of deuterium labelled 4'-hydroxydiclofenac[J]. J Label Compd Radiopharm, 1999,42 ( 11 ) : 1075 - 1083.
  • 7WU K Y,TIAN L,LI H Y,et al. Synthesis of deuterium labelled diclofenac with improved isotopic enrichment [ J ]. J Label Compd Radiopharm,2009,52 (13) :535 -537.
  • 8JANE R K,JAMES L M,MENG X L,et al. Syntheses and characterization of the acyl glucuronide and hydroxy metabolites of diclofenac[J].J Med Chem, 2004,47 ( 11 ) :2816 - 2825.
  • 9EDWARD C T, FRANK K, ROGER L, et al. Thalli- urn in organic synthesis. XX III. Electrophilic aromatic thallation kinetics and applications to orientation control in the synthesis of aromatic iodides [ J ]. J Am Chem Soc, 1971,93 (19) :4845 - 4850.
  • 10VIBHA B O,CRAIG S, PRAKASH R, et al. Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors [J]. J Med Chem,2002,45(2) :321 -332.

二级参考文献25

  • 1郭涛,郑春丽,宋洪涛,隋因,党大胜,孙学惠.双氯芬酸钠脉冲控释微丸的研究[J].药学学报,2003,38(9):707-710. 被引量:15
  • 2Riess W, Stierlin H, Degen P, et al. Pharmacokinetics and metabolism of the anti-inflammatory agent voltaren [ J ]. Scand J Rhcumatol Suppl, 1978, 22:17 - 29.
  • 3Terhaag B, Gramatte T, Hrdlcka P, et al. The influence of food oo the absorption of diclofenac as a pure substance[J]. Int J Clin Pharmacol Ther Toxicol, 1991, 29(10):418-421.
  • 4Idkaidek NM, Amidon GL, Smith DE, et al. Determination of the population pharmacokinetic parameters of sustained-release and entericcoated oral fomnulations, and the suppository formulation of diclofenac sodium by simultaneous data fiuing using NONMEM [ J ]. Biopharm Drug Dispos, 1998, 19(3): 169 - 174.
  • 5Terhaag B, Hoffmann A, Barkworth M, et al. Bioavailability of anew effervescent tablet of diclofenac[J]. Iht J Clin Pharmacol Ther, 2000,38(11) :546 - 551.
  • 6Sajeev C, Vinay G, ArchnaR, et al. Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl celulose[ J].J Microencapsul, 2002,19(6) :753 - 760.
  • 7Thakker KM, Mangat S, WagnerW, et al. Effect of food and reative bio,lability following single doses of didofenac 150 mg hydrogel bead (HGB) capsules in healthy humans[J]. Biopharm Drug Dispos, 1992,13(5) :327 - 335.
  • 8Riad LE, Sawchuk RJ, McAlary MM, et al. Effect of Food on the Multiple-Peak Behavior After a Single Oral Dose of Diclofenac Sodium Slow-Release Tablet in Humans[J]. Am J Ther, 1995, 2(4) :237 -242.
  • 9Ramakrishna S, Fadnavis NW, Diwan PV. Compative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans[J]. Arzneimittelforscbung, 1996, 46(2): 175 - 177.
  • 10Yong CS, Choi YK, Kim YI, et al. Physicochemical characterization and in vivo evaluation of thermosensitive diclofenac liquid suppository [J]. Arch Pharm Res, 2003, 26(2): 162 - 167.

共引文献7

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部